Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-15

Clinical Trial Update: Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Xenon and cooling therapy for babies at high risk of brain injury after birth asphyxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenon (xenon)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Hypoxic Ischaemic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED